These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 33982470)

  • 1. [Development of clinical trial of new drugs of traditional Chinese medicines].
    Yang ZQ; Tang YQ; DU YP; Tang HM; Zhang L; Gao R; Hu SY; Tang JY; Yuan WA
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1691-1695. PubMed ID: 33982470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research and development strategy of new traditional Chinese medicine drugs for syndromes based on human use experience].
    Yang ZQ; He XL; Liu DH; Tang YQ; Tang HM; Ling Y; DU YP
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):849-852. PubMed ID: 38621889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].
    Yang ZQ; Tang HM; Tang YQ; DU YP; Yuan WA; Li B; Zou C; Tang JY; Gao R; Hu SY; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1686-1690. PubMed ID: 33982469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment of multiple evidence-integrated evaluation and prediction method for "toxic" Chinese medicines].
    Cui HR; Zhang XY; You LZ; Zheng R; Chen Z; Jiang Y; Zhang JJ; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2266-2272. PubMed ID: 35531744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].
    Zou C; Ding H; Gao R; Hu SY; Liu JZ; Li B; Li XH; Pan DJ; Tang JY; Tong XY; Wang JY; Yuan WA; Zhang X; Zhang M; Zhao YL; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1696-1700. PubMed ID: 33982471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
    Ai YL; Tang JY; Zhou G; Zhang L; Qu LP; Huang SY; Yang ZQ; Yuan WA; Zhou YH; Wang T; Zhao JN; Sun XB; Xiao XH; Yang ZF; Liu QQ; Zhu MJ; Leng XY; Xie CG; Chai SY
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1120-1125. PubMed ID: 35285213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence-based Chinese medicine：theory and practice].
    Zhang JH; Li YP; Zhang BL
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):1-7. PubMed ID: 29552804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
    Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on key issues of quality control in clinical trials of new drugs of traditional Chinese medicine].
    Yuan WA; Tang JY; Gao R; Hu SY; Zhao YL; Zou C; Li B; Zhang JH; Zhang L; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1701-1705. PubMed ID: 33982472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral traditional Chinese medication for adhesive small bowel obstruction.
    Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
    Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance].
    Wang ZY; Wang X; Zhang DY; Hu YJ; Li S
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):7-17. PubMed ID: 35178906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
    Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2291-2295. PubMed ID: 32495582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research and development of new traditional Chinese medicine drugs for certain syndromes based on "theoretical innovation"].
    Lian MA; Ke-Bin W; Sheng-Xian WU
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5048-5056. PubMed ID: 33350282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
    Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].
    Zhao J; Ye Z
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2193-8. PubMed ID: 23189716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical changes and countermeasures for transformation of traditional Chinese medicine preparations in medical institutions into new drugs based on human use experience].
    Liu DH; He XL; Ni SH; Tang YQ; Tang HM; Lu L; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):565-568. PubMed ID: 38403331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevant thoughts on development of traditional Chinese medicine industry in new era].
    Huang J; Li G; Zhang XX; Ma Y; Zhan ZL; Yuan WA; Qu LP; Huang SY; Li B; Yan BH; Li WY; Liu L; Wang ZL; Feng Y; Zhang L; Tang JY
    Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4799-4813. PubMed ID: 36164887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of clinical efficacy evaluation system based on optimal clinical experience].
    Yang ZQ; Tang YQ; Tang HM; Ling Y; DU YP; Ni SH; Long WJ
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4829-4833. PubMed ID: 37802824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.